In July 2023, the European Medicines Agency 206 and the UK Medicines and Healthcare products Regulatory Agency (MHRA) 230 started a review of these medications safety following reports of worsening mood and suicidal behavior observed in GLP-1RA users
The now-elevated calcium levels promote exocytosis of GLP-1containing vesicles, releasing GLP-1 into the circulation
10.3389/fbinf.2025.1687617 Front Bioinform
A weight loss plateau during GLP-1 treatment is a common occurrence and usually happens as your body adapts to the changes
The standard starting dose is 2 mg once weekly, based on Phase 2 and Phase 3 clinical trials
Note: GLP-1 brands include Victoza, Trulicity, Saxenda, Ozempic, Rybelsus, Wegovy, and Mounjaro